Clinical hypnosis for velo-cardio-facial syndrome: A case series and therapeutic framework

Velo-Cardio-Facial Syndrome (VCFS) is associated with significant psychological and psychiatric comorbidities, including anxiety, depression, and psychosis. This case series explores the use of clinical hypnosis as a treatment to attenuate comorbid mental symptoms and enhance quality of life for individuals with VCFS. Sixteen cases aged 6 to 38 with genetically confirmed VCFS and psychological disorders were taught self-hypnosis and positive reframing. Caregivers assisted participants with practicing self-hypnosis and monitoring progress. Outcomes were assessed qualitatively based on symptomatic improvements reported by caregivers and patients across clinical visits. Treatment efficacy appeared influenced by patient engagement, caregiver support, and strategically directed hypnotic suggestions. Findings suggest therapy with hypnosis appears to be a low-cost, non-pharmacological approach for reducing anxiety, improving emotional-regulation, and alleviating some psychotic symptoms in VCFS.

Authors

Institutions

Publication Details

Journal
American Journal of Clinical Hypnosis
Published
2026-01-02
DOI
https://doi.org/10.1080/00029157.2025.2612470
Primary Topic
Congenital heart defects research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical hypnosis for velo-cardio-facial syndrome: A case series and therapeutic framework

Mac E. Lancaster, Ran D. Anbar, Robert J. Shprintzen, Zennen B. Dellalonga
American Journal of Clinical Hypnosis
Congenital heart defects research
article

Clinical hypnosis for velo-cardio-facial syndrome: A case series and therapeutic framework

Mac E. Lancaster, Ran D. Anbar, Robert J. Shprintzen, Zennen B. Dellalonga
article en

Abstract

Velo-Cardio-Facial Syndrome (VCFS) is associated with significant psychological and psychiatric comorbidities, including anxiety, depression, and psychosis. This case series explores the use of clinical hypnosis as a treatment to attenuate comorbid mental symptoms and enhance quality of life for individuals with VCFS. Sixteen cases aged 6 to 38 with genetically confirmed VCFS and psychological disorders were taught self-hypnosis and positive reframing. Caregivers assisted participants with practicing self-hypnosis and monitoring progress. Outcomes were assessed qualitatively based on symptomatic improvements reported by caregivers and patients across clinical visits. Treatment efficacy appeared influenced by patient engagement, caregiver support, and strategically directed hypnotic suggestions. Findings suggest therapy with hypnosis appears to be a low-cost, non-pharmacological approach for reducing anxiety, improving emotional-regulation, and alleviating some psychotic symptoms in VCFS.

American Journal of Clinical HypnosisVol. 68(1)
Center Point (US), Virtual High School (US)
Openalex Percentile: Top 66%
Congenital heart defects research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.